Cortical Neurons in Dementia with Lewy Bodies

Cortical Neurons in Dementia with Lewy Bodies

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cortical Neurons in Dementia with Lewy Bodies</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>DLB</td>
</tr>
<tr>
<td class="label">Primary protein</td>
<td>α-Syn</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortical neurons</td>
<td>Diffuse loss</td>
</tr>
<tr>
<td class="label">Pathology type</td>
<td>Lewy bodies</td>
</tr>
</table>

Introduction

Cortical Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Dementia with Lewy bodies (DLB) is characterized by widespread cortical involvement with Lewy body pathology affecting multiple brain regions. Cortical neurons, particularly pyramidal cells and interneurons, demonstrate significant degeneration that underlies the cognitive, psychiatric, and motor features of the disease. [@outeiro2023]

Neuroanatomy

Cortical Structure

Layer Organization

• Layer I: Molecular layer (sparse neurons)
• Layer II: External granular (small pyramids)
• Layer III: External pyramidal (pyramidal neurons)
• Layer IV: Internal granular (stellate cells)
• Layer V: Internal pyramidal (large pyramids)
• Layer VI: Multiform layer (polymorphic)

Neuron Types

...

Cortical Neurons in Dementia with Lewy Bodies

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cortical Neurons in Dementia with Lewy Bodies</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>DLB</td>
</tr>
<tr>
<td class="label">Primary protein</td>
<td>α-Syn</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortical neurons</td>
<td>Diffuse loss</td>
</tr>
<tr>
<td class="label">Pathology type</td>
<td>Lewy bodies</td>
</tr>
</table>

Introduction

Cortical Neurons In Dementia With Lewy Bodies is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Dementia with Lewy bodies (DLB) is characterized by widespread cortical involvement with Lewy body pathology affecting multiple brain regions. Cortical neurons, particularly pyramidal cells and interneurons, demonstrate significant degeneration that underlies the cognitive, psychiatric, and motor features of the disease. [@outeiro2023]

Neuroanatomy

Cortical Structure

Layer Organization

• Layer I: Molecular layer (sparse neurons)
• Layer II: External granular (small pyramids)
• Layer III: External pyramidal (pyramidal neurons)
• Layer IV: Internal granular (stellate cells)
• Layer V: Internal pyramidal (large pyramids)
• Layer VI: Multiform layer (polymorphic)

Neuron Types

Pyramidal Neurons

• Excitatory: Glutamatergic
• Apical dendrites: Extend to layer I
• Basal dendrites: Local connections
• Markers: Tuj1, Cux1, Satb2

GABAergic Interneurons

• Parvalbumin (PV): Fast-spiking
• Somatostatin (SST): Dendrite-targeting
• VIP: Interneuron-specific
• Reelin: Cajal-Retzius

Affected Cortical Regions

Primary Regions

• Frontal cortex: Executive dysfunction
• Temporal cortex: Memory, language
• Parietal cortex: Visuospatial
• Occipital cortex: Visual hallucinations

Connectivity

• Subcortical inputs: Thalamus, basal ganglia
• Cortical connections: Association fibers
• Neuromodulatory: Acetylcholine, 5-HT, NE

Pathophysiology in DLB

Lewy Body Pathology

α-Synuclein Accumulation

• Lewy bodies: Intraneuronal inclusions
• Lewy neurites: Axonal pathology
• Brainstem type: Early
• Cortical type: Diffuse

Distribution Pattern

• Temporal lobe: Early involvement
• Frontal cortex: Executive deficits
• Anterior cingulate: Psychiatric symptoms
• Primary sensory: Late

Mechanisms

α-Synuclein Toxicity

• Aggregation: Fibril formation
• Membrane binding: Membrane permeability
• Organelle dysfunction: Mitochondria, ER
• Synaptic dysfunction: Presynaptic terminals
• Spread: Prion-like propagation

Neurotransmitter Deficits

Cholinergic

• Severe loss: Up to 70% in cortex
• Basal forebrain: NBM degeneration
• Clinical correlation: Cognitive severity
• Treatment target: AChE inhibitors

Dopaminergic

• Substantia nigra: Moderate loss
• Motor symptoms: Parkinsonism
• Treatment implications: Levodopa

Serotonergic

• Raphe nuclei: Variable involvement
• Depression: Psychiatric features
• Hallucinations: 5-HT2A changes

Neuroinflammation

• Microglial activation: Chronic
• Cytokine elevation: IL-1β, TNF-α
• Astrocytic: Reactive changes
• Peripheral immune: Blood-brain barrier

Comparison with Alzheimer's

Electrophysiology

Cortical Dysfunction

Network Oscillations

• Alpha rhythm: Reduced power
• Beta oscillations: Slowed
• Gamma: Impaired coupling
• Cortical slowing: EEG delta/theta

Neuronal Excitability

• Pyramidal cells: Reduced firing
• Inhibitory neurons: Disinhibition
• Synaptic plasticity: LTPmechanisms/long-term-potentiation) impairment
• Cortical hyperexcitability: Early

Therapeutic Implications

Pharmacological

Cognitive Symptoms

• Cholinesterase inhibitors: Donepezil, rivastigmine
• Memantine: NMDA antagonist
• Limited efficacy: vs. AD

Psychiatric Symptoms

• Antipsychotics: Avoid (severe sensitivity)
• Pimavanserin: 5-HT2A inverse agonist
• Antidepressants: SSRIs, SNRIs

Motor Symptoms

• Levodopa: Modest benefit
• Dopamine agonists: Limited
• Parkinsonism: Variable response

Non-Pharmacological

• Cognitive stimulation: Benefit
• Physical exercise: Maintain function
• Sleep hygiene: REM behavior disorder
• Visual management: Reduce hallucinations

Disease-Modifying Approaches

• α-Syn aggregation inhibitors: In trials
• Immunotherapy: Active/passive
• Neurotrophic: Support neurons
• Anti-inflammatory: Modulation

Research Models

Animal Models

• α-Syn transgenic: A53T, A30P
• Viral vectors: AAV-α-syn
• Transgenic: Thy1-α-syn
• DLB models: Combined pathology

In Vitro Models

• iPSC cortical neurons: Patient-derived
• Neuronal cultures: α-Syn aggregation
• Organoids: Cortical circuits
• Co-cultures: Glia-neuron

Clinical Significance

Diagnostic Criteria

Core Features

• Fluctuating cognition: Variability
• Visual hallucinations: Detailed, formed
• Parkinsonism: Bradykinesia, rigidity
• REM sleep behavior disorder: Loss of atonia

Supportive Features

• Low uptake: DaTscan
• Prominent depression
• Delusions
• Sensitivity to antipsychotics

Biomarkers

• CSF: α-Synuclein (decreased)
• Imaging: MRI, PET
• Sleep: Polysomnography
• Genetics: GBA, SNCA

See Also

• [Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
• [Lewy Body Pathology
• [Alpha-Synuclein Pathway](/proteins/alpha-synuclein)
• Cortical Degeneration

](/brain-regions/lewy-body-pathology
--alpha-synuclein-pathway
--cortical-degeneration)## Background

The study of Cortical Neurons In Dementia With Lewy Bodies has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data